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Abstract: Objective: The ABO blood types are associated with cancers, cardiovascular disease, and Type 2 diabetes in 
adult males and females. Associations of ABO blood type and adverse pregnancy outcomes have not been extensively 
studied. The purpose of this study was to investigate the relationship with ABO blood groups and risk of adverse 
pregnancy outcomes contributing to premature birth.  
Study design: Data on ABO phenotypes and pregnancy outcomes were collected from the medical records of 1,462 
premature infants (22-34 weeks). Adverse pregnancy outcomes that were studied in relation to maternal blood type 
included gestational hypertension (GHTN), preeclampsia (PREE), chorioamnionitis (CA), preterm premature rupture of 
membranes (PPROM), and intrauterine growth restriction (IUGR) 
Results: 1,462 charts of mothers with premature infants (22-34 weeks) were studied measuring the relative risk by using 
standardized statistical software (SPSS).Our study group had 46 mothers with GHTN, 405 with PREE, 282 with CA, 504 
with PPROM, and 94 with IUGR. A+ Caucasian mothers had a 28% increased risk of developing preeclampsia (RR= 
1.28 (1.09-1.52); 95% CI= .003). B mothers are ata 46% decreased risk of developing chorioamnionitis versus all other 
blood groups (RR= 0.54, 95% CI= 0.36-0.81; P= .003). Conversely, O+ Caucasian mothers were 2.53 times more likely 
to develop chorioamnionitis compared to all other blood types (RR=2.53, 95% CI= 1.09-5.88; P= .031).  
Conclusions: Maternal ABO phenotype significantly influences the incidence of preeclampsia and chorioamnionitis. 
Pregnancy is a unique antigen-antibody phenomenon with the fetus serving as an antigen to the mother. We postulate 
that blood group antigen expression at the endothelial level may influence maternal disease states.  
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INTRODUCTION 
Recent studies have shown associations between 
particular ABO phenotypes and pathologic events 
including infection, cancer, thromboembolic disease 
and diabetes in adult male and females [1-6]. The A 
and B alleles encode specific enzymes that produce 
both A and B antigens. The O allele encodes an 
inactive enzyme with neither A or B antigen 
synthesized. Both A and B antigens are found on the 
surface of red blood cells and other tissue including 
vascular endothelium, epidermis and glandular or other 
epitheliums lining visceras. 
The association of ABO blood types on adverse 
pregnancy outcomes has been reported with varied  
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results. Blood groups A and O were associated with an 
increased risk for chorioamnionitis. Blood groups A or 
AB were found to increase the risk of preeclampsia. 
Other studies found blood group AB to be protective as 
well as a risk factor for gestational diabetes [7-12]. The 
goal of this study was to evaluate ABO blood types with 
common adverse pregnancy events that contribute to 
prematurity and infant mortality worldwide. We 
specifically examined gestational hypertension, 
preeclampsia, chorioamnionitis, preterm premature 
rupture of membranes and intrauterine growth 
restriction. 
METHODS 
This study was approved by the university’s 
Institutional Review Board and was conducted in 
compliance with the Health Insurance Portability and 
Accountability Act (HIPAA). We used Loyola 
University’s perinatal database (File Maker Pro), which 
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contains multiple data fields on demographic and 
clinical variables for mothers and neonates. We 
reviewed 1,462 charts of infants born at Loyola 
University Medical Center between January 1st 2008 to 
December 31st 2014, with premature gestational ages 
ranging from 22-34 weeks. In addition to our neonatal 
information (gestational age, birth weight, and race), 
several maternal dependent variables were reviewed in 
our population including gestational hypertension 
(GHTN), preeclampsia (PREE), chorioamnionitis (CA), 
preterm premature rupture of membranes (PPROM), 
and intrauterine growth restriction (IUGR). Independent 
variables reviewed included maternal age, race, and 
ABO phenotype.  
Criteria for inclusion in our study was documented 
maternal ABO phenotype and all premature infants 
born between January 1 2008-December 31 2014, with 
gestational age range 22-34 weeks. Chorioamnionitis is 
inflammation of the chorionic and amniotic layers of the 
fetal membranes confirmed by pathologic review of the 
placenta. Gestational hypertension is the development 
of new hypertension in a pregnant woman after 20 
weeks gestation without the presence of protein in the 
urine or other signs of preeclampsia. Hypertension is 
defined as having a blood pressure greater than 140/90 
mm Hg. Preeclampsia is defined as gestational 
hypertension with proteinuria. Preterm premature 
rupture of membranes is when the amniotic sac 
ruptures before 37 weeks of gestation and labor has 
not started within one hour. Intrauterine growth 
restriction is defined as a fetal weight that is below the 
10th percentile for gestational age as determined 
through ultrasound compared to expected growth 
parameters [13]. 
Differences between maternal blood groups 
developing selected clinical outcomes were calculated 
by measuring the relative risk by using standardized 
statistical software (SPSS). 
RESULTS 
In total, we found 282 mothers who had 
chorioamnionitis recorded in our database. (Table 1) 
O+ Caucasian mothers were found to be 2.53 times 
more likely to develop CA compared to all other blood 
groups (RR= 2.53, 95% CI= 1.09-5.88; P= 0.031). 
(Table 2) Conversely, B mothers (B+ and B-) are at a 
46% decreased risk of developing CA versus all other 
blood groups (RR= 0.54, 95% CI= 0.36-0.81; P= 
0.003). (Table 3) A+ Caucasian mothers were found to 
have a 28% increased risk of developing preeclampsia 
(RR= 1.28 (1.09-1.52); 95% CI= .003). (Table 4, Table 
5). Of the 282 babies with CA (see Table 1) and 
405 with PREE (see Table 4), their relative risk of 
developing each condition was significantly different by 
blood group. 
Table 1: Chorioamnionitis by ABO Phenotype in Our 
Population 
Blood Group Overall 
A- 18 (6%) 
A+ 92 (33%) 
B- 2 (0.007%) 
B+ 20 (7%) 
AB- 0 (0%) 
AB+ 6 (2%) 
O- 16 (6%) 
O+ 128 (45%) 
Total 282 
 
Table 2: O+ Phenotype and Increased Risk of 
Chorioamnionitis 
 +Chorioamnionitis -Chorioamnionitis 
O+ Caucasian 10 27 
All Others 8 67 
RR 2.53 1.09-5.88 
P 0.031  
 
Table 3:  Protective Effect of B Phenotype 
 + Chorioamnionitis -Chorioamnionitis 
B+/ B- 22 176 
All Others 260 1004 
RR 0.54 0.36-0.81 
P 0.003  
 
Table 4: Preeclampsia by ABO Phenotype in Our 
Population 
Blood Group Overall 
A- 12 (3%) 
A+ 158 (39%) 
B- 4 (0.009%) 
B+ 44 (11%) 
AB- 8 (0.02%) 
AB+ 14 (0.03%) 
O- 16 (0.04%) 
O+ 149 (37%) 
Total 405 
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Table 5:  A+ Phenotype and Increased Risk of 
Preeclampsia 
 +Preeclampsia -Preeclampsia 
A+ 158 327 
All Others 247 727 
RR 1.28 1.09-1.52 
P 0.003  
DISCUSSION 
The four major blood groups in humans are based 
on the presence of A and B antigens on the surface red 
blood cells. Both A and B antigens are found not only 
on the surface of red blood cells, but also on many 
other tissues, epithelial and endothelial linings. The 
approximate ABO distribution in the United States is O 
type (44%), A type (42%), B type (10%), and AB type 
(4%) [14]. Despite their common prevalence as “histo-
blood” antigens, an important corollary to recognize 
about these carbohydrate antigens is that there still is 
no known physiologic function for them. Absent this 
knowledge, their relationship as risk factors to disease 
states makes understanding mechanisms of associated 
diseases more difficult to appreciate. 
It is known that anti-A and anti-B antibodies 
(isohemagglutanins) are primarily of the IgM isotype, 
whereas the O antibodies are chiefly of IgG isotype. 
IgM isohemagglutinins are endogenously synthesized 
in the first years of life due to “natural” sensitization 
from exposure to environmental substances, such as 
food, bacteria (such as Enterobacteriaceae), or viruses 
[15]. The relative lack of IgM antibodies in individuals 
with the O blood group could predispose mothers to an 
increased risk of chorioamnionitis. It can further be 
hypothesized that O blood type mothers inherently 
lacking these antibodies and being in an physiologically 
immune-modulated pregnancy state, may be less 
predisposed to mount an antibody and/or complement-
mediated defense along the choriodecidual space and 
amniotic membranes. A study by Aly, et al. found blood 
types A and O are associated with increased risk for 
chorioamnionitis [16]. Our study produced similar 
results in that Caucasian O+ mothers were 2.53 times 
more likely to develop CA compared to all other blood 
groups. 
A+ Caucasian mothers were at increased risk of 
PREE compared to other phenotypes. Mothers with B 
phenotype, overall, were more protected from 
complications of the dependent variables in our study. 
Our hypothesis that blood group antigen expression on 
the endothelial surface may influence maternal disease 
states is strongly represented in our CA and PREE 
findings. It has been shown in previous studies that 
maternal ABO phenotype may play a role in 
unfavorable pregnancy outcomes. Phaloprakarn et al. 
and Alpoim et al. concluded that maternal ABO 
phenotypes AB and A were associated with increased 
risk of preeclampsia [17-18]. In our study population 
our findings were similar to Phaloprakarn, et al. and 
Alpoim, et al.: Mothers with the A phenotype were at an 
increased risk of preeclampsia. 
A previous study by Thomson, et al., demonstrated 
an increased risk of AB phenotype in relation to active 
or passive humoral factors (isoagglutinin hypotheses) 
showing that neonatal blood type is associated with the 
mortality in necrotizing enterocolitis (NEC). They found 
that neonates with AB blood group were indeed at 
significantly higher risk of mortality from NEC 
compared to neonates with other blood groups (HR 
2.87; 95% CI 1.40 to 6.589; P= 0.003) [19]. The 
authors concluded that a humoral immune reaction 
between blood group antigens on the neonatal 
gastrointestinal mucosa and passively transferred 
isoagglutinins may have a role in the development of 
NEC. A further study by Manuat et al., established the 
morphologic relationship of A and B antigens and 
isoagglutinins as expressed on intestinal endothelium 
using immunohistochemical staining. They found that 
blood group antigens, A more than B or AB together, 
may increase the risk of a neonate to develop NEC in 
the presence of passively or actively transferred 
isoagglutinins [20]. 
Limitations in our study include retrospective study, 
a cohort from a single academic institution, surveying 
only relative risks and established expanded maternal 
“risk markers” (simple associations) to be distinguished 
from risk factors (cause-effect relationships). Strengths 
of our study included sample size, heterogeneity of our 
population, as well as consistent ABO phenotype 
breakdown as to be statistically expected in the Unites 
States. We had statistically significant and strong 
correlations between maternal ABO phenotype and our 
additional dependent variables.  
We are encouraged to continue to seek further 
associations to support the role of maternal ABO 
phenotype and adverse outcomes as they apply to the 
neonate. We have found maternal ABO phenotypes to 
significantly affect the rates of CA and PREE. Further 
randomized prospective studies are needed to 
ascertain if maternal ABO phenotype significantly 
54    International Journal of Gynecology, Obstetrics and Neonatal Care, 2016, Vol. 3, No. 3 Reisig et al. 
influences the incidence and severity of maternal intra-
partum disease states. By identifying at-risk mothers 
based on blood type, potential early interventions could 
optimize maternal and neonatal outcomes. 
There are no disclaimers or conflicts of interest. 
REFERENCES 
[1] Risch H, Lu L, Wang J et al. ABO Blood Group and Risk of 
Pancreatic Cancer: A Study in Shanghai and Meta-Analysis. 
American Journal of Epidemiology. 2013; 177(12): 1326-
1337.  
http://dx.doi.org/10.1093/aje/kws458 
[2] Welsby I, Phillips-Bute B, Mathew J et al. ABO blood group 
influences transfusion and survival after cardiac surgery. 
Journal of Thrombosis and Thrombolysis 2014; 38(3): 402-
408.  
http://dx.doi.org/10.1007/s11239-013-1045-2 
[3] Reilly J, Meyer N, Shashaty M et al. ABO Blood Type A Is 
Associated With Increased Risk of ARDS in Whites Following 
Both Major Trauma and Severe Sepsis Chest 2014; 145(4): 
753-761.  
http://dx.doi.org/10.1378/chest.13-1962 
[4] Vasan S, Rostgaard K, Majeed A et al. ABO Blood Group 
and Risk of Thromboembolic and Arterial DiseaseCLINICAL 
PERSPECTIVE. Circulation 2016; 133(15): 1449-1457.  
http://dx.doi.org/10.1161/CIRCULATIONAHA.115.017563 
[5] Chen Z, Yang S, Xu H, Li J. ABO blood group system and 
the coronary artery disease: an updated systematic review 
and meta-analysis. Sci Rep 2016; 6: 23250.  
http://dx.doi.org/10.1038/srep23250 
[6] Afoakwah R, Boampong J, Aubyn E. Association of ABO 
blood groups and complicated Plasmodium falciparum 
malaria in Accra, Ghana. International Journal of Infectious 
Diseases 2012; 16: e150.  
http://dx.doi.org/10.1016/j.ijid.2012.05.340 
[7] Franchini M, Crestani S, Frattini F, Mengoli C, Bonfanti C. 
Relationship between ABO blood group and bleeding 
complications in orally anticoagulated patients. Journal of 
Thrombosis and Haemostasis 2012; 10(8): 1688-1691.  
http://dx.doi.org/10.1111/j.1538-7836.2012.04785.x 
[8] Seyfizadeh N, Seyfizadeh N, Yousefi B et al. Is there 
association between ABO blood group and the risk factors of 
unfavorable outcomes of pregnancy?.The Journal of 
Maternal-Fetal & Neonatal Medicine 2014; 28(5): 578-582.  
http://dx.doi.org/10.3109/14767058.2014.927424 
[9] Lee B, Zhang Z, Wikman A, Lindqvist P, Reilly M. ABO and 
RhD Blood Groups and Gestational Hypertensive Disorders. 
Obstetric Anesthesia Digest 2013; 33(4): 206.  
http://dx.doi.org/10.1097/01.aoa.0000436322.83488.7e 
[10] Shibata-Hiraizumi Y, Suzuki S. Maternal ABO blood group 
and adverse pregnancy outcomes in Japanese population. J 
Perinatol 2013; 33(9): 743-743.  
http://dx.doi.org/10.1038/jp.2013.81 
[11] Shimodaira M, Yamasaki T, Nakayama T. The association of 
maternal ABO blood group with gestational diabetes mellitus 
in Japanese pregnant women.Diabetes & Metabolic 
Syndrome: Clinical Research & Reviews 2016.  
http://dx.doi.org/10.1016/j.dsx.2016.03.003 
[12] Zhang C, Li Y, Wang L et al. Blood group AB is protective 
factor for gestational diabetes mellitus: a prospective 
population-based study in Tianjin, China. 
Diabetes/Metabolism Research and Reviews 2015; 31(6): 
627-637.  
http://dx.doi.org/10.1002/dmrr.2650 
[13] Gabbe S. Obstetrics. Philadelphia: Elsevier/Saunders; 2012 
[14] Reid, ME; Mohandas, N. "Red blood cell blood group 
antigens: structure and function". Seminars in hematology 
2004; 41(2): 93-117 
http://dx.doi.org/10.1053/j.seminhematol.2004.01.001 
[15] Galinsky R, Polglase G, Hooper S, Black M, Moss T. The 
Consequences of Chorioamnionitis: Preterm Birth and 
Effects on Development. Journal of Pregnancy 2013; 2013: 
1-11.  
http://dx.doi.org/10.1155/2013/412831 
[16] Aly H, Alhabashi G, Hammad T, Owusu-Ansah S, Bathgate 
S, Mohamed M. ABO Phenotype and Other Risk Factors 
Associated with Chorioamnionitis. J Pediatr 2008; 153(1): 16-
18.  
http://dx.doi.org/10.1016/j.jpeds.2008.02.008 
[17] Alpoim P, de Barros Pinheiro M, Junqueira D et al. 
Preeclampsia and ABO blood groups: a systematic review 
and meta-analysis. Molecular Biology Reports 2012; 40(3): 
2253-2261.  
http://dx.doi.org/10.1007/s11033-012-2288-2 
[18] Phaloprakarn C ,Tangjitgamol S. Maternal ABO blood group 
and adverse pregnancy outcomes. J Perinatol 2012; 33(2): 
107-111.  
http://dx.doi.org/10.1038/jp.2012.73 
[19] Thomson T, Habeeb O, DeChristopher P, Glynn L, Yong S, 
Muraskas J. Decreased survival in necrotizing enterocolitis is 
significantly associated with neonatal and maternal blood 
group: the AB isoagglutinin hypothesis. J Perinatol 2011; 
32(8): 626-630.  
http://dx.doi.org/10.1038/jp.2011.150 
[20] L Manuat CJ Yong S. Immunohistochemical Demonstration 
of Blood Group Antigen Expression in Intestinal Endothelium 
Links Blood Type and Necrotizing Enterocolitis. J Neonatal 
Biol 2014; 05(01). 
http://dx.doi.org/10.4172/2167-0897.1000211 
 
Received on 16-09-2016 Accepted on 11-10-2016  Published on 30-11-2016 
 
http://dx.doi.org/10.15379/2408-9761.2016.03.03.01 
© 2016 Reisig et al.; Licensee Cosmos Scholars Publishing House. 
This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License 
(http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, 
provided the work is properly cited. 
 
